{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:18:35Z","timestamp":1761513515678,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.clbc.2016.10.001","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T04:32:41Z","timestamp":1476851561000},"page":"e53-e57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Does Conservative Surgery for Breast Carcinoma Still Require Axillary Lymph Node Evaluation? A Retrospective Analysis of 1156 Consecutive Women With Early Breast Cancer"],"prefix":"10.1016","volume":"17","author":[{"given":"Antonio","family":"Marrazzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9844-2434","authenticated-orcid":false,"given":"Giuseppe","family":"Damiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietra","family":"Taormina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Buscemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attilio Ignazio","family":"Lo Monte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Marrazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2016.10.001_bib1","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial","volume":"252","author":"Giuliano","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2016.10.001_bib2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2016.10.001_bib3","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/cncr.28499","article-title":"Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial INT09\/98","volume":"120","author":"Agresti","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2016.10.001_bib4","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1200\/JCO.2013.54.1177","article-title":"Sentinel lymph node biopsy for patients with early-stage breast cancer: ASCO clinical practice guideline update","volume":"32","author":"Lyman","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2016.10.001_bib5","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/annonc\/mdv221","article-title":"Tailoring therapies\u2014improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015","volume":"26","author":"Coates","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2016.10.001_bib6","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.breast.2012.06.013","article-title":"Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs. Observation after axillary UltraSouND)","volume":"21","author":"Gentilini","year":"2012","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2016.10.001_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000360411","article-title":"Local treatment of the axilla in early breast cancer: concepts from the national surgical adjuvant breast and bowel project B-04 to the planned intergroup sentinel mamma trial","volume":"9","author":"Reimer","year":"2014","journal-title":"Breast Care"},{"key":"10.1016\/j.clbc.2016.10.001_bib8","first-page":"621","article-title":"Localization of the sentinel node in breast cancer: prospective comparison of vital staining and radioactive tracing methods","volume":"56","author":"Marrazzo","year":"2004","journal-title":"Chir Ital"},{"key":"10.1016\/j.clbc.2016.10.001_bib9","first-page":"693","article-title":"Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?","volume":"59","author":"Marrazzo","year":"2007","journal-title":"Chir Ital"},{"key":"10.1016\/j.clbc.2016.10.001_bib10","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","article-title":"Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011","volume":"25","author":"Lucci","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2016.10.001_bib11","first-page":"687","article-title":"Surgical treatment of breast cancer in day surgery","volume":"59","author":"Marrazzo","year":"2007","journal-title":"Chir Ital"},{"key":"10.1016\/j.clbc.2016.10.001_bib12","first-page":"105","article-title":"The sentinel node biopsy is not contraindicated in multifocal breast carcinoma","volume":"16","author":"Marrazzo","year":"2011","journal-title":"Eur J Oncol"},{"key":"10.1016\/j.clbc.2016.10.001_bib13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijsu.2014.05.020","article-title":"Localization of sentinel lymph node in breast cancer. A prospective study","volume":"12","author":"Marrazzo","year":"2014","journal-title":"Int J Surg"},{"key":"10.1016\/j.clbc.2016.10.001_bib14","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djj158","article-title":"Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial","volume":"98","author":"Mansel","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2016.10.001_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10549-005-9025-7","article-title":"Post-operative arm morbidity and quality of life: results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer","volume":"95","author":"Fleissig","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2016.10.001_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10549-006-9192-1","article-title":"Factors affecting failed localisation and false- negative rates of sentinel node biopsy in breast cancer: results of the ALMANAC validation phase","volume":"99","author":"Goyal","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2016.10.001_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1245\/s10434-013-3200-6","article-title":"Axillary dissection can be avoided in the majority of clinically node negative patients undergoing breast-conserving therapy","volume":"21","author":"Dengel","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2016.10.001_bib18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ejso.2016.01.020","article-title":"Physical function of the upper limb after breast cancer surgery. Results from the SOUND (Sentinel node vs. Observation after axillary Ultra-souND) trial","volume":"42","author":"Gentilini","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2016.10.001_bib19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1245\/s10434-013-3229-6","article-title":"Value of preoperative ultrasound-guided axillary lymph node biopsy for preventing completion axillary lymph node dissection in breast cancer: a systematic review and meta-analysis","volume":"21","author":"Diepstraten","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2016.10.001_bib20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/SLA.0b013e31821f1564","article-title":"Preoperative ultrasound-guided needle biopsy of axillary nodes in invasive breast cancer: meta-analysis of its accuracy and utility in staging the axilla","volume":"254","author":"Houssami","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2016.10.001_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jamcollsurg.2013.01.064","article-title":"Preoperative axillary ultrasound in breast cancer: safely avoiding frozen section of sentinel lymph nodes in breast-conserving surgery","volume":"217","author":"Ibrahim-Zada","year":"2013","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.clbc.2016.10.001_bib22","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2016.10.001_bib23","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/annonc\/mdt151","article-title":"The standard tangential fields used for breast irradiation do not allow optimal coverage and dose distribution in axillary levels I-II and the sentinel node area","volume":"24","author":"Belkacemi","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2016.10.001_bib24","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/bjs.7360","article-title":"Systematic review of the effect of external beam radiation therapy to the breast on axillary recurrence after negative sentinel lymph node biopsy","volume":"98","author":"van Wely","year":"2011","journal-title":"Br J Surg"},{"key":"10.1016\/j.clbc.2016.10.001_bib25","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.breast.2013.07.054","article-title":"Incidental radiation to axilla in early breast cancer treated with intensity modulated tangents and comparison with conventional and 3D conformal tangents","volume":"22","author":"Kataria","year":"2013","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2016.10.001_bib26","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa020128","article-title":"Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation","volume":"347","author":"Fisher","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2016.10.001_bib27","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/jnci\/88.21.1529","article-title":"Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor positive tumors","volume":"88","author":"Fisher","year":"1996","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2016.10.001_bib28","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1200\/JCO.1996.14.7.1982","volume":"14","author":"Fisher","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2016.10.001_bib29","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa052122","article-title":"Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer","volume":"353","author":"Romond","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2016.10.001_bib30","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1200\/JCO.2002.20.5.1304","article-title":"Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes","volume":"20","author":"Rouzier","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2016.10.001_bib31","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.2007.14.5565","article-title":"Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish breast","volume":"26","author":"Kyndi","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2016.10.001_bib32","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1245\/s10434-011-1665-8","article-title":"Impact of breast cancer molecular subtypes on locoregional recurrence in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer","volume":"18","author":"Meyers","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2016.10.001_bib33","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/bcr3198","article-title":"Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy","volume":"14","author":"Caudle","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2016.10.001_bib34","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10549-011-1891-6","article-title":"Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype","volume":"133","author":"Lowery","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2016.10.001_bib35","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijsu.2015.07.702","article-title":"Breast cancer subtypes can be determinant in the decision making process to avoid surgical axillary staging: a retrospective cohort study","volume":"21","author":"Marrazzo","year":"2015","journal-title":"Int J Surg"},{"key":"10.1016\/j.clbc.2016.10.001_bib36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3816\/CBC.2008.n.028","article-title":"Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer","volume":"8","author":"Crabb","year":"2008","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2016.10.001_bib37","doi-asserted-by":"crossref","first-page":"181e187","DOI":"10.1007\/s10549-008-9914-7","article-title":"Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive","volume":"113","author":"Van Calster","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2016.10.001_bib38","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.humpath.2006.04.015","article-title":"Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2\/neu-overexpressing phenotypes","volume":"37","author":"Kim","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1016\/j.clbc.2016.10.001_bib39","doi-asserted-by":"crossref","first-page":"e20297","DOI":"10.1371\/journal.pone.0020297","article-title":"The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma","volume":"6","author":"Reyal","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2016.10.001_bib40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10549-015-3549-2","article-title":"Meta-analysis to determine the clinical impact of axillary lymph node dissection in the treatment of invasive breast cancer","volume":"153","author":"Joyce","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2016.10.001_bib41","doi-asserted-by":"crossref","first-page":"513780","DOI":"10.1155\/2014\/513780","article-title":"Sentinel node biopsy alone versus completion axillary node dissection in node positive breast cancer: systematic review and meta-analysis","volume":"2014","author":"Ram","year":"2014","journal-title":"Int J Breast Cancer"},{"key":"10.1016\/j.clbc.2016.10.001_bib42","doi-asserted-by":"crossref","first-page":"e3254","DOI":"10.1097\/MD.0000000000003254","article-title":"The extent of axillary surgery is associated with breast cancer\u2013specific survival in T1-2 breast cancer patients with 1 or 2 positive lymph nodes: a SEER-population study","volume":"95","author":"Li","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.clbc.2016.10.001_bib43","first-page":"620","article-title":"Predictive factors for non-sentinel lymph node metastasis in the case of positive sentinel lymph node metastasis in two or fewer nodes in breast cancer","volume":"7","author":"Toshikawa","year":"2015","journal-title":"J\u00a0Clin Med Res"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820916303652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820916303652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:14:51Z","timestamp":1761513291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820916303652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1526820916303652"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2016.10.001","relation":{},"ISSN":["1526-8209"],"issn-type":[{"type":"print","value":"1526-8209"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does Conservative Surgery for Breast Carcinoma Still Require Axillary Lymph Node Evaluation? A Retrospective Analysis of 1156 Consecutive Women With Early Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2016.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}